Hetta, H.F.; Mekky, M.A.; Sayed, H.I.; Soliman Mahran, A.A.; Salama, E.H.; Sayed, D.; Abdallah, M.E.; Mohamed, D.S.; El-Badawy, O.; El-Mokhtar, M.A.
Impact of Sofosbuvir Plus Daclatasvir Therapy on the Frequency of CD200R+ Dendritic Cells in Chronic Hepatitis C Virus Infection. Immuno 2025, 5, 2.
https://doi.org/10.3390/immuno5010002
AMA Style
Hetta HF, Mekky MA, Sayed HI, Soliman Mahran AA, Salama EH, Sayed D, Abdallah ME, Mohamed DS, El-Badawy O, El-Mokhtar MA.
Impact of Sofosbuvir Plus Daclatasvir Therapy on the Frequency of CD200R+ Dendritic Cells in Chronic Hepatitis C Virus Infection. Immuno. 2025; 5(1):2.
https://doi.org/10.3390/immuno5010002
Chicago/Turabian Style
Hetta, Helal F., Mohamed A. Mekky, Hani I. Sayed, Ahmed AbdElkader Soliman Mahran, Eman H. Salama, Douaa Sayed, Mariam E. Abdallah, Doaa Safwat Mohamed, Omnia El-Badawy, and Mohamed A. El-Mokhtar.
2025. "Impact of Sofosbuvir Plus Daclatasvir Therapy on the Frequency of CD200R+ Dendritic Cells in Chronic Hepatitis C Virus Infection" Immuno 5, no. 1: 2.
https://doi.org/10.3390/immuno5010002
APA Style
Hetta, H. F., Mekky, M. A., Sayed, H. I., Soliman Mahran, A. A., Salama, E. H., Sayed, D., Abdallah, M. E., Mohamed, D. S., El-Badawy, O., & El-Mokhtar, M. A.
(2025). Impact of Sofosbuvir Plus Daclatasvir Therapy on the Frequency of CD200R+ Dendritic Cells in Chronic Hepatitis C Virus Infection. Immuno, 5(1), 2.
https://doi.org/10.3390/immuno5010002
